Study determines costs of breast and cervical cancer detection among low-income women

	Tweet

A new study has estimated the costs of providing comprehensive screening and diagnostic services to under-or uninsured, low-income women to identify those with breast or cervical cancer for treatment. Dr. Donatus U. Ekwueme of the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control and Prevention in Atlanta and colleagues found that the median cost of screening a woman for breast cancer was $94, and the cost per breast cancer detected was $10,566. For cervical cancer, these costs were $56 and $13,340, respectively. The study is published in the February 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Many deaths from breast and cervical cancer would be avoidable through the use of mammography and Pap tests, respectively. 

In 1990 Congress established the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)—which is now the largest cancer screening program in the United States—to provide support and assistance to increase breast and cervical cancer screening among medically under-served, low-income women. Program services are available in all 50 states, the District of Columbia (DC), 4 U.S. territories, and 13 American Indian/Alaskan Native organizations. To help determine the level of funding required to reach and screen eligible women, Ekwueme and colleagues set out to estimate the costs per woman served, per woman screened and per cancer detected through this program.

The investigators collected data from July 2003 through June 2004 from nine of the 68 NBCCEDP programs operating in the United States. They found that when non-federal contributions are included, the median cost of all screening services combined was $555 per woman. Screening tests accounted for the highest cost, $221 per woman served, and public education/outreach incurred the second highest cost, $63.

The analysis revealed that 58.2 percent of the program’s resources were allocated to clinical services, including screening and diagnostic follow-up, referral for treatment, and case management. The remainder of NBCCEDP’s funds were used to support non-screening activities such as data management, public education/outreach, professional education and quality assurance and improvement.

The authors note that the study “provides the first systematic cost analysis in the selected [NBCCEDP] programs and is unique in that it attempts to determine the real costs of providing comprehensive screening and diagnostic follow-up services to low-income, uninsured women.” The Centers for Disease Control and Prevention is currently assessing the long-term economic issues in all of the programs within NBCCEDP. These analyses “will provide invaluable information that program directors and managers can use to make informed decisions on how to allocate NBCCEDP resources more efficiently,” the authors conclude.

###

Article: “Cost Analysis of the National Breast and Cervical Cancer Early Detection Program—Selected States, 2003-2004.” Donatus U. Ekwueme, James G. Gardner, Sujha Subramanian, Florence K. Tangka, Bela Bapat, and Lisa C. Richardson. CANCER; Published Online: December 21, 2007 (DOI: 10.1002/cncr.23207); Print Issue Date: February 1, 2008.

Contact: Office of Communications, National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention, 770-488-5131,

Contact: Amy Molnar

Wiley-Blackwell

RELATED STORIES:
Peptide Delivers One-Two Punch to Breast Cancer in Pre-Clinical Study   UK mothers back cervical cancer vaccine for kids   Black women often refuse breast cancer treatment   Weight Gain/Risk of Breast Cancer in Postmenopausal Women   Personality-breast cancer link debunked   Avastin helps breast cancer patients: study   Cough medicine could help doctors identify how breast cancer patients metabolize tamoxifen   HPV screen-and treat-intervention effective in cervical cancer prevention   Breast Cancer & the Environment   Roche drugs, chemo destroy 46 percent of breast tumors   Second breast cancer may be greater than thought for high-risk women without BRCA mutations   8 Natural Ways to Prevent Breast Cancer   Scientists identify ‘gatekeepers’ of breast cancer transition to invasive disease   Coils almost halve risk of cervical cancer: study   Mammography Study in BMJ Flawed: Discredited Data Used   New Dubin Breast Center at Mount Sinai Raises the Standard for Comprehensive Cancer Care   Fertility procedures need not delay breast cancer treatment for younger women   Future in which Breast Cancer Will Be Cured or Controlled   Fat stem cells safe for breast reconstruction when cancer is dormant, says Pitt team   Genes set scene for metastasis   Soy isoflavones not a risk for breast cancer survivors   Wine May Provide Radioprotective Effect for Breast Cancer Patients

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]